NCT00483899View on ClinicalTrials.gov

Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 7, 2005

Primary Completion Date

December 15, 2006

Study Completion Date

December 15, 2006

Conditions
Asthma
Interventions
DRUG

GW870086X

Subjects will inhale 0.25 or 1.5 mg/inhalation GW870086X for four times

DRUG

Placebo

Placebo matching GW870086X will be administered by subjects

Trial Locations (3)

M23 9LT

GSK Investigational Site, Manchester

SE5 8AF

GSK Investigational Site, London

Unknown

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00483899 - Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects | Biotech Hunter | Biotech Hunter